
Combination therapy pill could reduce stroke risk by 40%
A single pill low-dose combination therapy could reduce the risk of recurrent stroke by almost 40%, trial results show. GMRx2, developed by biopharmaceutical company George Medicines, reduced recurrent stroke risk in patients with previous intracerebral haemorrhage (ICH) by 39% compared to placebo, according to results published in the New… Read More






